Toxoplasma gondii

Wang, Lu, Zhai, Bintao, Wang, Chen, Elsheikha, Hany M., Guo, Haiting, Zheng, Xiao-Nan, Zhou, Chun-Xue & Zhu, Xing-Quan, 2024, Glabridin exhibits potent inhibitory effects against ToxoplaSMa gondii in vitro and in vivo, Parasites & Vectors (522) 17 (1), pp. 1-11 : 4

publication ID

https://doi.org/10.1186/s13071-024-06610-0

persistent identifier

https://treatment.plazi.org/id/03996048-F129-ED2D-FC8E-FA5A42EC6D33

treatment provided by

Felipe

scientific name

Toxoplasma gondii
status

 

Glabridin inhibits T. gondii growth in vitro

To assess the toxicity of glabridin on Vero cells in vitro, a CCK-8 assay was performed. Te results, shown in Fig. 1a View Fig , demonstrated that glabridin exhibited dosedependent cytotoxicity after 24 h. Specifically, at the concentration of 5 μg/ml, Vero cell growth remained at 99.05% of the control (P> 0.05). In contrast, exposure to 7.5 μg/ml of glabridin reduced the growth rate to 74.0% (P <0.0001). Tus, glabridin is considered safe for Vero cells at concentrations ≤ 5 μg/ml.

To evaluate the anti- T. gondii activity of glabridin, we examined the proliferation of RH strain tachyzoites treated with 5 μg/ml glabridin or 0.1% DMSO (vehicle). As shown in Fig. 1b View Fig , glabridin significantly (P <0.0001) inhibited the extracellular activity of T. gondii tachyzoites in a time-dependent manner. Additionally, we assessed its effects on intracellular parasites. Host cells were infected with RH tachyzoites for 3 h, after which extracellular parasites were removed, and fresh media containing either 0.1% DMSO or glabridin was added. After 48 h of culture, glabridin significantly reduced the growth of intracellular T. gondii tachyzoites, as shown in Fig. 1c View Fig (P <0.0001).

Darwin Core Archive (for parent article) View in SIBiLS Plain XML RDF